Schroder Investment Management Group’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-74,000
| Closed | -$2.23M | – | 1248 |
|
|
2024
Q4 | $2.23M | Hold |
74,000
| – | – | ﹤0.01% | 910 |
|
|
2024
Q3 | $1.16M | Hold |
74,000
| – | – | ﹤0.01% | 1013 |
|
|
2024
Q2 | $1.27M | Hold |
74,000
| – | – | ﹤0.01% | 990 |
|
|
2024
Q1 | $1.16M | Hold |
74,000
| – | – | ﹤0.01% | 1002 |
|
|
2023
Q4 | $1.1M | Buy |
+74,000
| New | +$1.1M | ﹤0.01% | 1000 |
|
|
2022
Q2 | – | Sell |
-3,732
| Closed | -$314K | – | 1366 |
|
|
2022
Q1 | $314K | Buy |
3,732
+1,367
| +58% | +$115K | ﹤0.01% | 1267 |
|
|
2021
Q4 | $178K | Hold |
2,365
| – | – | ﹤0.01% | 1254 |
|
|
2021
Q3 | $275K | Hold |
2,365
| – | – | ﹤0.01% | 1292 |
|
|
2021
Q2 | $524K | Buy |
2,365
+755
| +47% | +$167K | ﹤0.01% | 1216 |
|
|
2021
Q1 | $213K | Sell |
1,610
-55,288
| -97% | -$7.31M | ﹤0.01% | 1317 |
|
|
2020
Q4 | $9.85M | Buy |
+56,898
| New | +$9.85M | 0.01% | 636 |
|